hypertension%20in%20pregnancy
HYPERTENSION IN PREGNANCY
Hypertension in pregnancy is defined as an average diastolic blood pressure of ≥90 mmHg, based on at least 2 measurements, ≥4 hr apart or systolic blood pressure of ≥140 mmHg taken at least 6 hr apart.
Diagnosis of severe hypertension is made when blood pressure is ≥160/110 mmHg.
Measurement should be repeated after 15 min for confirmation.

Introduction

Categories of Hypertension in Pregnancy

Chronic Hypertension

  • Defined as blood pressure (BP) measurement of >140/90 mmHg on 2 occasions prior to pregnancy or before 20 weeks of gestation; also used to refer to hypertension that is diagnosed for the first time during pregnancy and persists beyond 12 weeks postpartum
  • Risk of developing preeclampsia is increased

Gestational Hypertension

  • Refers to women who develop hypertension without proteinuria after 20 weeks of gestation
    • May correspond to the preproteinuric phase of preeclampsia or recurrence of chronic hypertension abated in midpregnancy
  • May progress to preeclampsia
  • A diagnosis that is made retrospectively if preeclampsia is not present at the time of delivery and blood pressure returns to normal by 12 weeks postpartum

Preeclampsia/Eclampsia

  • Term used to describe condition presenting as hypertension after 20 weeks of gestation, with 1 or more of the following:
    • Proteinuria (>300 mg/24 hours) or protein to creatinine ration >0.3 mg/dL
    • Hematologic disorder: Hemolysis, thrombocytopenia, coagulopathy
    • Liver problems: Elevated liver enzymes and/or severe epigastric or right upper quadrant pain
    • Neurologic signs: Severe headache, persistent visual disturbance (scotoma), hyperreflexia with clonus, seizures (eclampsia)
    • Renal insufficiency: Oliguria or serum creatinine >1.1 mg/dL or increase to twice the normal concentration without other renal disease
    • Pulmonary edema
    • Fetal growth restriction

Definition

Preeclampsia Superimposed on Chronic Hypertension

  • Also called preexisting hypertension plus superimposed gestational hypertension with proteinuria
  • Diagnosis is based on lab tests as above and should be used to distinguish between superimposed preeclampsia and worsening chronic hypertension
  • This refers to patients having preexisting hypertension or chronic hypertension with any of the following:
    • New onset proteinuria (≥3 g/24 hours) presents at >20 weeks of gestation
    • Proteinuria in <20 weeks of gestation but with increase in proteinuria
    • Sudden increase in BP that was previously well-controlled
    • Thrombocytopenia
    • Elevated liver enzymes

Risk Factors

Preeclampsia
  • Identify high-risk patients with normal blood pressure (BP) in early gestation for close monitoring to prevent preeclampsia
    • Nulliparity
    • Extremes of maternal age (<20 years or >40 years)
    • Chronic hypertension
    • History of hypertension in previous gestation before week 34
    • History of preeclampsia/eclampsia, intrauterine growth restriction (IUGR) or unexplained stillbirth
    • Family history of preeclampsia/eclampsia
    • Preexisting medical conditions [eg diabetes mellitus (DM), collagen vascular diseases, renal vascular or parenchymal diseases]
    • Multifetal pregnancy
    • Obesity or excessive weight gain >1 kg/week
    • Autoimmune disease, eg SLE or antiphospholipid antibody syndrome
Superimposed Preeclampsia
  • Renal insufficiency
  • History of hypertension >4 years
  • Hypertension in previous pregnancy
    • An increase in alanine aminotransferase (ALT) and aspartate aminotransferase (AST) to abnormal levels
Digital Edition
Asia's trusted medical magazine for healthcare professionals. Get your MIMS Cardiology - Malaysia digital copy today!
DOWNLOAD
Editor's Recommendations
Most Read Articles
4 days ago
Higher circulating levels of docosahexaenoic acid (DHA) and docosapentaenoic acid (DPA) appear to be protective against incident atherothrombotic and cardioembolic strokes, respectively, according to a recent study.
Roshini Claire Anthony, 6 days ago

The prevalence of resistant hypertension may be lower than expected, particularly once pseudo-resistant hypertension due to treatment nonadherence is taken into account, according to a presentation at the recent APCH 2017.

Pank Jit Sin, 07 Jan 2015

Cardiovascular diseases (CVD) have been the main cause of death in the Malaysian population since 2007. This trend has continued, with the number of people dying from CVD-related causes increasing year on year. 

Tristan Manalac, 6 days ago
Administration of a long-acting medication at the time that is most suitable for maximum patient compliance is the best approach in controlling blood pressure, said Dr. Trefor Morgan at the recently concluded 13th Asian-Pacific Congress of Hypertension (APCH 2017), held at the Suntec Singapore Convention and Exhibition Centre.